We treated active SLE B cells with AKT inhibitor, then we observed significantly decreased AKT protein phosphorylation and increased P53 protein and miR-1246 expression in AKT inhibitor-treated SLE B cells compared with the blank (PBS-treated) (Figure 9A, B, C). The gene discussed is TP53; the disease is systemic lupus erythematosus.